期刊文献+

重视非酒精性脂肪性肝硬化的早期诊断 被引量:4

Early diagnosis of nonalcoholic fatty liver cirrhosis
暂未订购
导出
摘要 非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)已成为全球肝硬化的重要原因之一,也可能是我国"不明"原因肝硬化的重要病因。介绍了NAFLD的进展机制及早期诊断方法。不同于HBV或HCV相关肝硬化,进一步明确NAFLD进展的诱因及临床特征,寻找有效的早期无创诊断方法,是今后重要的研究方向。 Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)has become one of the important causes of liver cirrhosis in the world and may be an important cause of unexplained liver cirrhosis in China.The mechanism of NAFLD progression and early diagnosis are described.The causes and clinical features of NAFLD progression,which are different from HBV or HCV-related cirrhosis, need to be further identified,and the effective noninvasive methods for early diagnosis remain to be well studied.
出处 《临床肝胆病杂志》 CAS 2014年第12期1357-1360,共4页 Journal of Clinical Hepatology
基金 北京市卫生局高层次人才学科带头人(2011-2-9) 学科骨干(2013-11 2013-12)
关键词 脂肪肝 肝硬化 早期诊断 综述 fatty liver liver cirrhosis early diagnosis review
  • 相关文献

参考文献3

二级参考文献3

共引文献41

同被引文献85

  • 1魏思忱,郑国启.脂肪因子在肝硬化发病机制中的作用[J].临床肝胆病杂志,2012,28(1):78-81. 被引量:5
  • 2巫国辉,赵锋,袁铿,李小林.瘦素对脂肪细胞的直接调节作用[J].中国美容医学,2007,16(10):1346-1349. 被引量:15
  • 3CHALASANI N, YOUNOSSI Z, LAINE JE, et al. The diagno- sis and management of non -alcoholic fatty liver disease: practice guideline by the American Gastroenterological Asso- ciation, American Association for the Study of Liver Disea- ses, and American College of Gastroenterology[ J]. Gastro- enteroloQy, 2012, 142/7). 1592-1609.
  • 4CONSIDINE RV. Human leptin: an adipocyte hormone with weight - regulatory and endocrine functions[ J ]. Semin Vasc Med, 2005, 5(1 ) : 15 -24.
  • 5FRUHBECK G. In tracellular singalling pathways activated by leptin[J]. BiochemJ, 2006, 393(1):7.
  • 6KOCH C, AUGUSTIN RA, STEGER J, et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity [ J ]. Neurosci, 2010, 30 (48) : 16180 -16187.
  • 7PETERSEN KF, ORAL EA, DUFOUR S, et al. Leptin rever- ses insulin resistance and hepatic steatosis in patients with severe lipodystrophy[J]. J Clin Invest, 2002, 109(10): 1345 - 1350.
  • 8GIATROMANOLAKI A, KOTSIOU S, KOUKOURAKIS MI, et al. Angiogenic factor expression in hepatic cirrhosis[J].Me- diators Inflamm, 2007, 67: 187.
  • 9DING X, SAXENA NK, LIN S, et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology[ J ]. Am J Pathol, 2005, 166(6) : 1655 -1669.
  • 10MAEDA N, SHIMOMURA I, KISHIDA K, et al. Diet-in- duced insulin resistance in mice lacking adiponectin/ACRP30 [J]. Nat Med, 2002, 8(5): 2654 -2660.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部